3-119812794-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003889.4(NR1I2):c.628A>G(p.Lys210Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003889.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR1I2 | NM_003889.4 | c.628A>G | p.Lys210Glu | missense_variant | 5/9 | ENST00000393716.8 | NP_003880.3 | |
NR1I2 | NM_022002.3 | c.745A>G | p.Lys249Glu | missense_variant | 5/9 | NP_071285.1 | ||
NR1I2 | NM_033013.3 | c.520-3A>G | splice_region_variant, intron_variant | NP_148934.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR1I2 | ENST00000393716.8 | c.628A>G | p.Lys210Glu | missense_variant | 5/9 | 1 | NM_003889.4 | ENSP00000377319.3 | ||
NR1I2 | ENST00000337940.4 | c.745A>G | p.Lys249Glu | missense_variant | 5/9 | 1 | ENSP00000336528.4 | |||
NR1I2 | ENST00000466380.6 | c.520-3A>G | splice_region_variant, intron_variant | 1 | ENSP00000420297.2 | |||||
NR1I2 | ENST00000493757.1 | n.760A>G | non_coding_transcript_exon_variant | 2/6 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | The c.628A>G (p.K210E) alteration is located in exon 5 (coding exon 4) of the NR1I2 gene. This alteration results from a A to G substitution at nucleotide position 628, causing the lysine (K) at amino acid position 210 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.